<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03405987</url>
  </required_header>
  <id_info>
    <org_study_id>T1-strain-2436</org_study_id>
    <nct_id>NCT03405987</nct_id>
  </id_info>
  <brief_title>Association of T1-mapping and LV Strain Analysis by CMR</brief_title>
  <official_title>Association of T1-mapping and LV Strain Analysis by CMR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The association of T1-mapping (both native and ECV) and strain analysis of LV and RV by CMR
      will be assessed. Results from strain analysis will be investigated in terms of their
      prognostic value.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association of native LV T1-values and strain analysis</measure>
    <time_frame>Baseline</time_frame>
    <description>Association of native LV T1-values and strain analysis by CMR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Association of ECV and strain analysis</measure>
    <time_frame>Baseline</time_frame>
    <description>Association of ECV and strain analysis by CMR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Association of strain analysis and outcome</measure>
    <time_frame>2 years</time_frame>
    <description>Association of strain analysis by CMR and outcome (combination of cardiovascular hospitalization or death)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myocardial Fibrosis</condition>
  <arm_group>
    <arm_group_label>ECV &lt; median</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ECV ≥ median</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Strain analysis by CMR</intervention_name>
    <description>Strain analysis by CMR will be performed</description>
    <arm_group_label>ECV &lt; median</arm_group_label>
    <arm_group_label>ECV ≥ median</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing CMR for whatever reason will be invited to participate.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing CMR

          -  willingness to participate

        Exclusion Criteria:

          -  &lt;18 years old

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andreas Kammerlander, MD</last_name>
    <phone>014040046140</phone>
    <email>andreas.kammerlander@meduniwien.ac.at</email>
  </overall_contact>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2018</study_first_submitted>
  <study_first_submitted_qc>January 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>January 14, 2018</last_update_submitted>
  <last_update_submitted_qc>January 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Andreas Kammerlander</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

